Quantitative Systematic Strategies LLC Global Blood Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 15, 2019	SELL	$39.99 - $53.48 $324,758 - $434,311	-8,121 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $256,136 - $379,007	8,121 New	8,121 $333,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $170,962 - $229,898	-4,499 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$38.7 - $50.15 $174,111 - $225,624	4,499 New	4,499 $203,000
Q4 2017 Feb 01, 2018	SELL	$29.7 - $45.7 $226,759 - $348,919	-7,635 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$25.1 - $31.05 $191,638 - $237,066	7,635	7,635 $237,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.